menu
    • menu

    Company profile for Traws Pharma

    NEW Drugs in Dev: 11
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Traws Pharma is advancing as a clinical-stage biopharmaceutical enterprise, specializing in the development of small molecule oral product candidates tailored for respiratory viral diseases and cancer. Within the realm of viral respiratory illnesses, Traws Pharma is actively pursuing the creation of an oral inhibitor targeting SARS-CoV-2 Mpro (3CL protease). Additionally, the company is spearheading the development of a novel ...
    Traws Pharma is advancing as a clinical-stage biopharmaceutical enterprise, specializing in the development of small molecule oral product candidates tailored for respiratory viral diseases and cancer. Within the realm of viral respiratory illnesses, Traws Pharma is actively pursuing the creation of an oral inhibitor targeting SARS-CoV-2 Mpro (3CL protease). Additionally, the company is spearheading the development of a novel oral antiviral drug candidate designed for influenza.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Traws PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Newtown, PA 18940
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.trawspharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Traws Files IND for Tivoxavir Marboxil in Influenza Therapy
    Traws Files IND for Tivoxavir Marboxil in Influenza Therapy

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217637/0/en/Traws-Pharma-Files-Tivoxavir-Marboxil-Investigational-New-Drug-IND-Application-for-Influenza-Therapy-and-Provides-Updated-Results-from-the-Ongoing-Clinical-Study-of-Ratutrelvir-in-.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    Traws Pharma: Positive Interim Data with Ratutrelvir vs. PAXLOVID
    Traws Pharma: Positive Interim Data with Ratutrelvir vs. PAXLOVID

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206814/0/en/Traws-Pharma-Reports-Positive-Interim-Clinical-Data-with-Ratutrelvir-Versus-PAXLOVID-Shows-Activity-in-PAXLOVID-Ineligible-COVID-19-Patients.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    Traws Pharma Unveils Q3 2025 Results & Key Achievements
    Traws Pharma Unveils Q3 2025 Results & Key Achievements

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187155/0/en/Traws-Pharma-Reports-Third-Quarter-2025-Results-and-Business-Highlights.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    ChemDiv Extends CMC Collaboration For Ratutrelvir In Ph 2 Trial
    ChemDiv Extends CMC Collaboration For Ratutrelvir In Ph 2 Trial

    30 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/chemdiv-extends-cmc-services-collaboration-for-ratutrelvir-a-potential-best-in-class-covid-19-therapeutic-advancing-in-phase-2-clinical-trials-302599828.html

    PR NEWSWIRE
    30 Oct 2025
    Share Share
    Expert Systems Backs Traws Pharma's Ratutrelvir Phase 2 COVID-19
    Expert Systems Backs Traws Pharma's Ratutrelvir Phase 2 COVID-19

    22 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dover-delaware--expert-systems-inc-a-leading-life-sciences-accelerator-supports-traws-pharma-phase-2-clinical-studies-of-ratutrelvir--a-novel-ritonavir-free-antiviral-for-covid-19-302592063.html

    PR NEWSWIRE
    22 Oct 2025
    Share Share
    Traws Pharma Initiates Phase 2 Ratutrelvir Trial In COVID Studies
    Traws Pharma Initiates Phase 2 Ratutrelvir Trial In COVID Studies

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166002/0/en/Traws-Pharma-Doses-First-Patient-with-Ratutrelvir-in-Phase-2-COVID-Studies-Expects-Results-by-Year-End-2025.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search